MEDIA STATEMENT
NICE has today (17 August 2021) taken the decision to pause publication of its updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS).
Similar Posts
Why is Britain now the capital of long Covid?
Response to letter in Times: https://www.thetimes.co.uk/article/why-is-britain-now-the-capital-of-long-covid-grjpvzfvw Dear Editor This report was both disappointing and poorly researched in the…
Retirement of the Countess of Mar as Chair of Forward-ME
That this House marks the retirement of the Countess of Mar as the Founding Chair of Forward-ME; congratulates…
Charity COVID-19 vaccine statement
STATEMENT ON VACCINATION CHOICE BY MEDICAL ADVISORS 25% Group members are naturally asking for advice as to whether…
Life-Threatening Malnutrition in Very Severe ME/CFS
Abstract Very severe Myalgic Encephalomyelitis (ME), (also known as Chronic Fatigue Syndrome) can lead to problems with nutrition…
ME AWARENESS 2022
ME Awareness 2022 “Core Guidance NG206: Key extracts from the ME/CFS guideline published by NICE October 2021, with…
PrecisionLife and Metrodora Institute share first insights with ME/CFS, Long COVID participants in MetX research study
MetX Study Shares First Results with Participants